Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Craddock, C, Houlton, A, Ferguson, P, Raghavan, M, Fox, S, Dudley, L, Quek, L, Cavenagh, J, Dennis, M, McMullin, M, Pillai, S, Kelly, R, Siddique, S, Wheatley, K, Vyas, P
Формат:	Conference item
Хэвлэсэн:	American Society of Hematology 2016

Ижил төстэй зүйлс

Molecular predictors of response to azacitidine therapy: the results of the UK trials acceleration programme RAVVA study
-н: Craddock, C, зэрэг
Хэвлэсэн: (2017)

Outcome of azacitidine therapy in acute myeloid leukemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature
-н: Craddock, C, зэрэг
Хэвлэсэн: (2017)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
-н: Craddock, C, зэрэг
Хэвлэсэн: (2013)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.
-н: Craddock, C, зэрэг
Хэвлэсэн: (2013)

INDUCTION OF A CDS+ T CELL RESPONSE TO THE MAGE CANCER TESTIS ANTIGEN BY COMBINED TREATMENT WITH AZACITIDINE AND SODIUM VALPROATE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASIA
-н: Goodyear, O, зэрэг
Хэвлэсэн: (2010)

FACTORS DETERMINING CLINICAL RESPONSE TO 5 '-AZACITDINE AND SODIUM VALPROATE COMBINATION THERAPY IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASIA
-н: Craddock, C, зэрэг
Хэвлэсэн: (2010)

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia.
-н: Goodyear, O, зэрэг
Хэвлэсэн: (2010)

Real‐world study of the use of azacitidine in myelodysplasia in Australia
-н: Anoop Enjeti, зэрэг
Хэвлэсэн: (2024-06-01)

5 ' Azacitidine in Combination with Valproic Acid Induces Complete Remissions in Patients with Advanced Acute Myeloid Leukaemia but Does Not Eradicate Clonal Leukaemic Stem/Progenitor Cells.
-н: Craddock, C, зэрэг
Хэвлэсэн: (2008)

5 ' AZACITIDINE IN COMBINATION WITH VALPROIC ACID INDUCES COMPLETE REMISSIONS IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKAEMIA BUT DOES NOT ERADICATE CLONAL LEUKAEMIC STEM/PROGENITOR CELLS
-н: Craddock, C, зэрэг
Хэвлэсэн: (2009)

Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure
-н: Thomas Prébet, зэрэг
Хэвлэсэн: (2013-02-01)

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
-н: John F. Seymour, зэрэг
Хэвлэсэн: (2017-12-01)

Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study
-н: Roland B. Walter, зэрэг
Хэвлэсэн: (2014-01-01)

Heterogeneous genetic and non-genetic mechanisms contribute to response and resistance to azacitidine monotherapy
-н: Symeonidou, V, зэрэг
Хэвлэсэн: (2022)

Vorinostat-An overview
-н: Aditya Kumar Bubna
Хэвлэсэн: (2015-01-01)

Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities.
-н: Dennis, M, зэрэг
Хэвлэсэн: (2013)

The AGILE trial of ivosidenib plus azacitidine versus azacitidine alone: How many limitations is too many?
-н: Anjali Bhatt, зэрэг
Хэвлэсэн: (2022-11-01)

Vorinostat in solid and hematologic malignancies
-н: Richon Victoria M, зэрэг
Хэвлэсэн: (2009-07-01)

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).
-н: Goodyear, O, зэрэг
Хэвлэсэн: (2012)

Myelodysplasia in children with anorectal malformations
-н: Karine Furtado Meyer, зэрэг
Хэвлэсэн: (2006-09-01)

Chromosomal deletions in myelodysplasia.
-н: Boultwood, J, зэрэг
Хэвлэсэн: (1995)

Temozolomide-Induced Myelodysplasia
-н: Ethan A. Natelson, зэрэг
Хэвлэсэн: (2010-01-01)

Solving the mystery of myelodysplasia.
-н: Jerald Radich
Хэвлэсэн: (2008-02-01)

Heterogeneous genetic and non‐genetic mechanisms contribute to response and resistance to azacitidine monotherapy
-н: Vasiliki Symeonidou, зэрэг
Хэвлэсэн: (2022-08-01)

Antioxidants impair anti-tumoral effects of Vorinostat, but not anti-neoplastic effects of Vorinostat and caspase-8 downregulation.
-н: Laura Bergadà, зэрэг
Хэвлэсэн: (2014-01-01)

Sweet's syndrome and neutrophilic panniculitis associated with G-CSF treatment in a patient with myelodysplasia
-н: Brown, V, зэрэг
Хэвлэсэн: (2008)

Magrolimab + azacitidine versus azacitidine + placebo in untreated higher risk myelodysplastic syndrome: the Phase 3, randomized, ENHANCE Study
-н: Garcia-Manero, G, зэрэг
Хэвлэсэн: (2021)

Myelodysplasia Rehabilitation in Children: a Review
-н: Anna M. Nekrasova, зэрэг
Хэвлэсэн: (2024-10-01)

G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial
-н: Tomáš Stopka, зэрэг
Хэвлэсэн: (2022-07-01)

New Insights on Iron Study in Myelodysplasia
-н: Noha M. El Husseiny, зэрэг
Хэвлэсэн: (2014-12-01)

Introduction to the Review Series on Myelodysplasia
-н: Moshe Mittelman
Хэвлэсэн: (2025-01-01)

Acquired spherocytosis in the setting of myelodysplasia
-н: Linda Katharina Karlsson, зэрэг
Хэвлэсэн: (2022-01-01)

Hemophagocytic Lymphohistiocytosis Complicating Myelodysplasia
-н: Geraldine Quintero-Platt, зэрэг
Хэвлэсэн: (2014-03-01)

Bone marrow immunity and myelodysplasia
-н: Claude LAMBERT, зэрэг
Хэвлэсэн: (2016-07-01)

Magrolimab + azacitidine versus azacitidine + placebo in untreated higher risk (HR) myelodysplastic syndrome (MDS): the phase 3, randomized, ENHANCE study
-н: Garcia-Manero, G, зэрэг
Хэвлэсэн: (2021)

Magrolimab + azacitidine versus azacitidine + placebo in untreated higher risk (HR) myelodysplastic syndromes (MDS): the Phase 3, randomized, ENHANCE Study
-н: Garcia-Manero, G, зэрэг
Хэвлэсэн: (2021)

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
-н: DiNardo, CD, зэрэг
Хэвлэсэн: (2021)

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
-н: Eugène D.M.B. Kroon, зэрэг
Хэвлэсэн: (2020-09-01)

A pilot study of volumetric and density tumor analysis of ACC patients treated with vorinostat in a phase II clinical trial
-н: Molly Malarkey, зэрэг
Хэвлэсэн: (2023-08-01)

The effect of vorinostat on the development of resistance to doxorubicin in neuroblastoma.
-н: Timothy B Lautz, зэрэг
Хэвлэсэн: (2012-01-01)